FirmNewsDeal AnnouncementSVB Securities Serves as Exclusive Financial Advisor to Asceneuron on its Licensing Agreement with Ferrer for ASN90 for the Treatment of Progressive Supranuclear Palsy (PSP)
SVB Securities Serves as Exclusive Financial Advisor to Asceneuron on its Licensing Agreement with Ferrer for ASN90 for the Treatment of Progressive Supranuclear Palsy (PSP)